---
schema_version: "secwatch.filing_event.v1"
accession: "0001077183-22-000083"
form_type: "8-K"
ticker: "NEO"
cik: "0001077183"
company_name: "NEOGENOMICS INC"
filed_at: "2022-05-11T23:59:59+00:00"
generated_at: "2026-06-25T20:21:30.397506+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# NeoGenomics names Vishal Sikri President of Inivata; Dr. Clive Morris retiring in June

## Summary
- Vishal Sikri appointed President and CCO of Inivata, effective May 23, 2022.
- Dr. Clive Morris to retire as President of Inivata effective June 30, 2022; settlement terms not yet determined.
- Dr. Gina Wallar, President of Pharma Services Division, resigning effective May 27, 2022; Jennifer Rose interim.
- Sikri receives base salary $510K, annual bonus target 50% of salary, sign-on bonus $500K, and equity grant $1.055M.

## SEC filing metadata
- accession: 0001077183-22-000083
- form_type: 8-K
- ticker: NEO
- cik: 0001077183
- company_name: NEOGENOMICS INC
- filed_at: 2022-05-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1077183/000107718322000083/0001077183-22-000083-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1077183/000107718322000083/neo-20220505.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001077183-22-000083
- JSON: https://secwatch.observer/filing/0001077183-22-000083.json
- Plain text: https://secwatch.observer/filing/0001077183-22-000083.txt

## Key facts
- Executive change
  Clive D. Morris departed as President of Inivata at NEOGENOMICS INC.
  - Action: retire
  - Role: President of Inivata
  source text: On May 5, 2022, Dr. Clive D. Morris, NeoGenomics, Inc.’s (the “Company”) current President of Inivata, informed the Company of his intention to retire from his role effective June 30, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1077183/000107718322000083/0001077183-22-000083-index.htm
- Executive change
  Vishal Sikri was appointed as President and Chief Commercial Officer, Inivata Division at NEOGENOMICS INC.
  - Action: appointed
  - Role: President and Chief Commercial Officer, Inivata Division
  source text: On May 9, 2022, the Company announced that Vishal Sikri, age 46, was appointed President and Chief Commercial Officer, Inivata Division, of the Company, effective May 23, 2022 (the “Effective Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1077183/000107718322000083/0001077183-22-000083-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.